Pooled analysis of GI tolerability of 21 randomized controlled trials of celecoxib and nonselective NSAIDs*

By Niculescu Liviu   Li Chunming   Huang Jim   Mallen Sharon  

Current Medical Research and Opinion, Vol. 25, Iss. 3, 2009-03 ,pp. : 729-740

Informa Healthcare

Access to resources Recommend Favorite

Gastrointestinal tolerability of NSAIDs in elderly patients: a pooled analysis of 21 randomized clinical trials with celecoxib and nonselective NSAIDs

By Mallen Sharon R.   Essex Margaret N.   Zhang Richard  

Current Medical Research and Opinion, Vol. 27, Iss. 7, 2011-07 ,pp. : 1359-1366

Informa Healthcare

Access to resources Recommend Favorite

Efficacy, safety and tolerability of aleglitazar in patients with type 2 diabetes: pooled findings from three randomized phase III trials

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 6, 2015-06 ,pp. : 560-565

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and Tolerability of Subcutaneous Methylnaltrexone in Patients with Advanced Illness and Opioid‐Induced Constipation: A Responder Analysis of 2 Randomized, Placebo‐Controlled Trials

By  

PAIN PRACTICE, Vol. 15, Iss. 6, 2015-07 ,pp. : 564-571

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cardiovascular safety of empagliflozin in patients with type 2 diabetes: a meta‐analysis of data from randomized placebo‐controlled trials

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 18, Iss. 10, 2016-10 ,pp. : 1034-1040

John Wiley & Sons Inc

Access to resources Recommend Favorite